4//SEC Filing
Machiels Alec 4
Accession 0001127602-23-024309
CIK 0001492422other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:24 PM ET
Size
10.8 KB
Accession
0001127602-23-024309
Insider Transaction Report
Form 4
Machiels Alec
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-09-15−1,250→ 3,750 totalExercise: $2.67Exp: 2023-12-04→ Common Stock (1,250 underlying) - Exercise/Conversion
Common Stock
2023-09-15$2.67/sh+1,250$3,338→ 368,670 total - Sale
Common Stock
2023-09-15$45.34/sh−1,250$56,675→ 367,420 total
Holdings
- 11,950(indirect: By Spouse)
Common Stock
- 250,000(indirect: By LLC)
Common Stock
- 150,000(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]This is a scheduled exercise and sale from 10B5-1 trading plan.
- [F2]The shares are held by Bauhaus 1 LLC, which LLC is held by The Irrevocable Agreement of Trust of Alec Machiels (the "Trust"). The reporting person is the managing member of Bauhaus 1 LLC and the trustee of the Trust.
- [F3]Owned by spouse.
- [F4]On September 7, 2021, the reporting person's spouse transferred 150,000 shares of Apellis Pharmaceuticals, Inc. common stock to her trust, of which the reporting person is the trustee.
- [F5]This option was granted on December 5, 2013 and fully vested.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001496687
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 4:24 PM ET
- Size
- 10.8 KB